This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Paris Diderot-Paris 7. Active years: 2015-2018.
Company Filing History:
2 out of 5,383 
2 out of 111 
Years Active: 2015-2018
Title: The Innovative Contributions of Thibaut Defever
Introduction
Thibaut Defever is a notable inventor based in Orchies, France, recognized for his significant contributions to the field of electrochemical identification of nucleotide sequences. With two patents to his name, his work showcases the intersection of biology and technology, paving the way for advancements in genetic identification and research.
Latest Patents
Defever's latest patents include a groundbreaking method for electrochemically identifying target nucleotide sequences. This innovative method involves several key steps: supplying a biological sample that may contain a predetermined target nucleotide sequence, and providing activatable amplification materials composed of free nucleotides to form replicated target nucleotide sequences. Additionally, the method incorporates an oxido-reducible compound that is positioned between the nucleotides during replication. Before an electric field is applied to the sample, the amplification materials are activated to ensure the oxido-reducible compound is functional. The crucial aspect of his invention lies in the replicated target sequences inhibiting the electrochemical activity of the inserted compound, allowing the detection of the predetermined target nucleotide sequence when the electric current decreases.
Career Highlights
Throughout his career, Thibaut Defever has worked with esteemed institutions such as Université Paris Diderot – Paris 7 and the Centre National de la Recherche Scientifique (CNRS). His tenure at these research organizations has allowed him to expand his expertise and contribute to significant scientific advancements.
Collaborations
Defever has collaborated with notable peers in his field, including Benoît Limoges and Damien Marchal. These collaborations have likely fostered an environment of shared knowledge and innovation, enhancing the development of his pioneering work in electrochemical methodologies.
Conclusion
Thibaut Defever's contributions to the fields of biotechnology and electrochemistry illustrate his commitment to innovation. His patents not only advance scientific understanding but also hold potential applications in various sectors, including medical diagnostics and genetic research. As a leading figure in his domain, Defever continues to inspire future generations of inventors and researchers.